US FDA/NORD Partnership Will Further Increase Patient Involvement In Drug Development

Agency's agreement with rare disease advocacy group will facilitate patient meetings with review divisions, as well as enhance communication of safety information.

Two businessmen shaking hands during a meeting in the office, success, dealing, greeting & business partner concepts - soft light.

The US FDA is partnering with a prominent rare disease advocate to increase the patient voice in drug approval and development in what appears to be another evolution in the agency's patient-focused drug development efforts.

A new memorandum of understanding (MOU) with the National Organization for Rare Disorders will allow collaboration to plan workshops,...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Rare Diseases

More from Pink Sheet